View this email in your browser

Latest news from the labs: how our research is bringing hope to cancer patients


Dear Voornaam,

On average, someone is diagnosed with cancer at least every 90 seconds in the UK. That means that by today, World Cancer Day, around 33,600 people would have already received a diagnosis this year.  

With your support, we can continue to make ground-breaking discoveries and develop kinder, smarter treatments, to help save more lives. Here are just some of our latest research discoveries.

Dr Alex Radzisheuskaya – one of the lead researchers involved in discovering potential treatments for acute myeloid leukaemia.

New treatment target for aggressive leukaemia  

Our researchers have identified a key weakness in acute myeloid leukaemia – a challenging cancer to treat – offering a promising new strategy to delay the progression of this aggressive blood cancer. 

Read more

Kate’s story 

The theme of this World Cancer Day is United by Unique, highlighting every human story behind the cancer. When diagnosed with advanced cancer, people can often assume the worst is imminent. Yet drugs like olaparib are giving people like Kate, who was diagnosed with advanced ovarian cancer five years ago, the chance to continue living life with their loved ones. 

Read more

New way to predict bowel cancer risk 

Using a new algorithm based on the pattern of the DNA altered in the pre-cancerous cells, our scientists can predict which people with IBD will go on to develop bowel cancer within 5 years.

Read more

Your support for ovarian and breast cancer research

Thanks to the support of people like you, we have raised nearly £120,000 for our ovarian and breast cancer appeal, giving people like Sue, Natasha, Sonia and thousands of women the hope of more precious time with their loved ones. If you haven't had a chance, there's still time to donate. Hear more from Professor Udai Banerji about the future of ovarian cancer research.

Read more

New drug hope for prostate cancer

Using a new drug that is currently in clinical trials for ovarian and bile duct cancer, NXP800, can slow the growth of prostate cancer cells, including those that are resistant to hormone therapy.

Read more

Our discoveries are only possible with your support. Thank you for making sure we can continue our life-saving research to defeat cancer.

Make a donation

Yours sincerely, 

Catherine Graham 
Joint Head of Fundraising Campaigns and Individual Giving 

Website
X
Facebook
Instagram
YouTube
Copyright © 2024 The Institute of Cancer Research

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
 
 ͏  ͏  ͏  ͏ ͏  ͏  ͏  ͏ ͏  ͏  ͏  ͏ ͏  ͏  ͏  ͏ ͏  ͏  ͏  ͏ ͏  ͏  ͏  ͏